CDC health advisory regarding swine influenza

The outbreak of disease in people caused by a new influenza virus of swine origin continues to grow in the United States and internationally.

The viruses contain a unique combination of gene segments that have not been reported previously among swine or human influenza viruses in the U.S. or elsewhere. At this time, CDC recommends the use of oseltamivir or zanamivir for the treatment of infection with swine influenza viruses. The H1N1 viruses are resistant to amantadine and rimantadine but not to oseltamivir or zanamivir. It is not anticipated that the seasonal influenza vaccine will provide protection against the swine flu H1N1 viruses.

• What to do if you get flu-like symptoms: http://www.cdc.gov/h1n1flu/sick.htm
  
  
• Frequently asked questions: http://www.cdc.gov/h1n1flu/qa.htm
  
  
• Taking care of a sick person at home: http://www.cdc.gov/h1n1flu/guidance_homecare.htm
  
  
• Clinical guidance on laboratory safety, case definitions, infection control and information for the public are available at http://www.cdc.gov/swineflu/investigation.htm.
  
  
• Swine Influenza A (H1N1) Virus Biosafety Guidelines for Laboratory Workers: http://www.cdc.gov/swineflu/guidelines_labworkers.htm
  
  
• Interim Guidance for Infection Control for Care of Patients with Confirmed or Suspected Swine Influenza A (H1N1) Virus Infection in a Healthcare Setting: http://www.cdc.gov/swineflu/guidelines_infection_control.htm
  
  
• Interim Guidance on Case Definitions for Swine Influenza A (H1N1) Human Case Investigations: http://www.cdc.gov/swineflu/casedef_swineflu.htm
  
  
• For more information about swine flu: http://www.cdc.gov/swineflu
  

Additional information is also available by calling 1-800-CDC-INFO (1-800-232-4636)